Munther Baara
Senior Director, Development Business Technology
Pfizer

Munther has over 20 years of experience in the pharmaceutical industry. He is currently Sr. Director of Development Business technology at Pfizer, a worldwide pharmaceutical company. Munther is currently the head of Clinical Paradigm within the WRD-BT Development at Pfizer, Munther is spearheading initiatives driving innovation in development operations to align with the paradigm shift in the clinical trials execution model and emerging technologies. Munther Led the Clinical Aggregation Layer (CAL) implementation of a high-profile, large-scale clinical private cloud of clinical and operational data. In addition, he has extensive experience in application and system strategies, best practices, and standards that work for clinical and enterprise architecture, information management, workflow/process automation and integration of both home-grown and commercial applications across mixed platforms.

Basker Gummadi, MS, PMP, PgMP
Director Clinical Information Systems
Bayer Healthcare

Basker Gummadi is a professional with over 22 years of experience and has a strong background in project, program management, technical architecture and business process modelling. He led several merger and acquisition efforts across global R&D organizations and delivered innovative, award winning global projects to realize strategic enterprise business goals.

He is very passionate about innovation and is an innovation coach. He mentored teams in Design Thinking and Systematic Inventive Thinking methodologies to foster innovation.

Basker has a great understanding of technology enablers like Artificial Intelligence, Machine Learning, Block Chain and Big Data. He is researching, collaborating, and exploring the right leverage of such technologies to execute Digital transformations. His current focus is on optimizing Clinical Trial with Block Chain, and providing Real World Evidence based solutions using Big Data.

Houman Shadab
Professor, New York Law School
Co-Director, The Accord Project

Houman Shadab is a prolific and influential expert in law, business, and technology, Houman is a professor at New York Law School and cofounder of Clause.io as well as a director of the open source legal technology consortium, the Accord Project. His areas of focus are legaltech and fintech, startups, supply chains and professional services, and blockchain. Houman has testified before the federal government several times, is widely published and cited, and also often advises a wide variety of companies.

Dr. Vahan Simonyan 
Lead Scientist, HIVE
R&D Director of Bioinformatics, FDA
Adjunct Professor, George Washington University

In 2017, the technology experts Dr. Simonyan (FDA) and Shahram Ebadollahi (IBM) have led a research collaboration between FDA and IBM on testing feasibility of blockchain for healthcare data. The initiative called Healthcare Data Exchange Framework (HDEF) targets the facilitation of healthcare data transactions by creating an incentive framework for patient ownership of their medical data.

Dr. Simonyan has a solid scientific background in varied academic disciplines: MS in Physical Organic Chemistry, Ph.D. in Quantum Physics and Mathematics, post-doctoral training in Nanotechnology and Quantum Statistical Thermodynamics. After 2001, he switched his expertise to biotechnology and biomedical informatics and currently serves at the FDA as a lead scientist of HIVE, R&D Director of Bioinformatics. Vahan is a prolific author of scientific publications in physics, chemistry, quantum chemistry, nanotechnology, biotechnology, population dynamics, and bioinformatics.

Additionally, Dr. Simonyan is an adjunct professor at the George Washington University, where he teaches and develops curriculums for biomedical big data informatics and biostatistics research and development courses.

In 2013, High-performance Integrated Virtual Environment (HIVE) codebase was donated by Dr. Simonyan to the US government in order to build a platform ready to accept NGS data at the US FDA for regulatory review. Today HIVE has supported regulatory review and research leading to peer-reviewed publications in genetics, genomics, proteomics, data modeling, and bioinformatics.

In 2016, Dr. Simonyan and his colleagues (Raja Mazumder and Jeremy Goecks) have published the first BioCompute paper where they introduced the new concept for bioinformatics harmonization. Today BioCompute is represented by a large international consortium of regulatory and research scientists from academia, industry, technology companies and government organizations.

Do You Want to Present at this Forum?

If you are interested in attending or presenting a session at this Forum, click the button on the right.

Submit Now